Viewing nowCombinationTelmizam 40/10mg
Telmisartan 40mg · Amlodipine Besylate 13.87mg
Tablet · Prescription medication · Combination
Hanwha Pharmaceutical Co., Ltd.

MFDS item code 201606833 · Approved 2016.11.30 · Insurance code 651602210
Treatment of essential hypertension not controlled with monotherapy
This medication is used for patients with essential hypertension who find it difficult to control blood pressure with either amlodipine or telmisartan monotherapy. This drug helps effectively control high blood pressure and stabilize it. When blood pressure is properly managed, it can reduce the risks of complications such as heart disease and stroke. It is prescribed according to the patient's condition and improves blood pressure control with consistent use.
The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. If possible, it is recommended to take it at the same time each day (e.g., in the morning). Before starting this medicine, it is recommended that the dose be adjusted using the individual components (amlodipine or telmisartan). However, if blood pressure is not controlled with the individual components as follows, switching directly to this medicine may be considered. - 40/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or this medicine 40/5 mg. - 40/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg. ○ Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. For patients with severe renal impairment, however, it is recommended to start treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 mg in patients with mild or moderate hepatic impairment. ◦ Older adults: The usual amlodipine regimen is recommended for older adults, but caution should be exercised when increasing the dose (see section ‘3. Patients requiring careful administration’). In patients 75 years of age or older, amlodipine clearance is reduced; therefore, treatment should be started at a low dose and the dose increased gradually.
The safety and efficacy of this medicine have not been established in pediatric patients 18 years of age or younger; therefore, its use is not recommended.
This medication can pose serious risks to the fetus during pregnancy, especially in the second and third trimesters; therefore, it should not be taken by women who are pregnant or may become pregnant. Patients allergic to the active ingredients or similar components, those with severe liver dysfunction, hypotension, or serious cardiovascular conditions should also avoid taking this medication. Patients with impaired liver function, gastrointestinal disorders, kidney diseases, those on dialysis, or elderly patients need special caution when using this medication. Common side effects such as dizziness and peripheral edema may occur, and serious side effects have been reported rarely; therefore, if any abnormal symptoms appear, immediate consultation with healthcare professionals is advised. Due to the risk of dangerously low blood pressure, if symptoms of hypotension appear, the patient should lie down immediately, and intravenous therapy may be necessary if needed. This medication may interact with other drugs; thus, if the patient is currently taking any medications, it is crucial to inform the doctor or pharmacist. Women who are breastfeeding should avoid taking this medication, and if pregnant or planning to become pregnant, safer treatment options should be selected. Use in children is not recommended as safety and efficacy have not been sufficiently established. In case of overdose, severe hypotension, dizziness, or cardiac issues may occur, so the dosage must strictly be adhered to, and any unusual symptoms should prompt an immediate visit to a medical institution. This medication should be kept out of the reach of children and used immediately after opening the package.
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to light and must be stored in a container that does not allow light to enter. Additionally, it is important to store the medication at room temperature, specifically between 1 to 30 degrees Celsius, to maintain its efficacy.
White or slightly off-white, biconvex oval tablets
10 tablets/Alu-Alu X 3, 30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationTelmisartan 40mg · Amlodipine Besylate 13.87mg
Tablet · Prescription medication · Combination
Hanwha Pharmaceutical Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
ILDONG Pharmaceutical Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.